Novartis AG
(NYSE : NVS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.27%130.780.7%$942.40m
PFEPfizer Inc.
-1.02%36.900.9%$755.01m
MRKMerck & Co., Inc.
-0.16%82.630.7%$614.29m
ABBVAbbVie, Inc.
-0.45%70.512.3%$551.14m
BMYBristol-Myers Squibb Company
-0.40%49.411.4%$446.07m
LLYEli Lilly and Company
-0.54%110.871.0%$340.63m
AZNAstraZeneca PLC Sponsored ADR
-0.33%42.761.2%$134.10m
NVSNovartis AG Sponsored ADR
-2.81%86.980.2%$129.52m
GSKGlaxoSmithKline plc Sponsored ADR
-0.37%40.880.3%$82.40m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.32%49.510.1%$68.02m
SNYSanofi Sponsored ADR
-0.21%43.710.2%$51.16m
LCILannett Company, Inc.
0.29%13.9335.6%$50.62m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.05%1.911.6%$2.42m
EPIXESSA Pharma Inc
-1.96%3.000.1%$0.18m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.